Astrana Health, Inc. (NASDAQ:ASTH) Shares Purchased by Swiss National Bank

Swiss National Bank increased its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 1.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 88,444 shares of the company’s stock after buying an additional 1,000 shares during the period. Swiss National Bank’s holdings in Astrana Health were worth $2,789,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Quarry LP acquired a new stake in shares of Astrana Health in the third quarter worth $77,000. KBC Group NV boosted its holdings in Astrana Health by 108.4% in the fourth quarter. KBC Group NV now owns 2,530 shares of the company’s stock valued at $80,000 after purchasing an additional 1,316 shares during the last quarter. Quest Partners LLC acquired a new stake in Astrana Health during the 3rd quarter worth about $133,000. US Bancorp DE raised its stake in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company’s stock valued at $151,000 after buying an additional 4,656 shares during the last quarter. Finally, Paloma Partners Management Co acquired a new position in shares of Astrana Health in the 3rd quarter valued at about $220,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Price Performance

Shares of NASDAQ ASTH opened at $30.79 on Thursday. The firm has a market cap of $1.54 billion, a price-to-earnings ratio of 23.68, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company’s 50-day simple moving average is $33.99 and its 200-day simple moving average is $42.18. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 52-week low of $23.12 and a 52-week high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. Equities analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Stifel Nicolaus reduced their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 20th. Robert W. Baird cut their target price on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Bank of America lowered their price target on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a report on Tuesday, March 4th. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Truist Financial lowered their target price on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Astrana Health currently has an average rating of “Moderate Buy” and an average target price of $56.17.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.